In patients treated with antidiabetic medications with bona fide anti-inflammatory properties, reduced CRP, inflammatory cytokines, and endothelial dysfunction, along with increased adiponectin were observed. This evidence concerns the gene ADIPOQ and endothelial dysfunction.